US Patent Issued to Genevive on July 29 for "Proteins for the treatment of epithelial barrier function disorders" (California Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,456, issued on July 29, was assigned to Genevive Inc. (Wilmington, Del.).

"Proteins for the treatment of epithelial barrier function disorders" was invented by Andrew Wonhee Han (Brisbane, Calif.), Andrew W. Goodyear (Brisbane, Calif.), Tarunmeet Gujral (Brisbane, Calif.), Todd Zachary DeSantis (Brisbane, Calif.) and Karim Dabbagh (Brisbane, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure related to therapeutic proteins and pharmaceutical compositions comprising said proteins, which have utility in treating various human diseases. In particular aspects, the disclosed therapeutic proteins are useful for treating human gastrointes...